Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 26 2021

Lobular Carcinoma In Situ (LCIS)

  • Snapshot
    • A 62-year-old women presents to her primary care physician with a mass in the right breast, which she believes was the result of trauma. On exam there is a firm, fixed 1 cm mass in the right breast in the upper outer quandrant. There is no axillary lyphadenopathy.
  • Introduction
    • Overview
      • a non-invasive lesion due to proliferative changes within the breast lobule
      • not a premalignant lesion
      • considered a risk factor for breast cancer
        • if untreated LCIS will become invasive in 20-30% of patients over a prolonged period of time (10-15 years)
        • 7-11x higher risk of developing invasive breast cancer in a patient with LCIS
          • contralateral cancer can either be ductal or lobular
          • majority are estrogen and progesterone positive
  • Epidemiology
    • Incidence
      • ~10% of "malignant" lesions on mammogram
      • lifetime risk is 1% per year
    • Risk factors
      • age > 40 years
      • family history of breast cancer
      • hormone replacement therapy
    • Genetics
      • mutations
        • LCIS cells are usually estrogen/progesterone receptor-positive and HER2/neu-negative
  • Presentation
    • Symptoms
      • asymptomatic
      • breast lump
    • Physical exam
      • breast lump may be detected on exam or may not be palpable
  • Imaging
    • Mammography
      • indications
        • screening
          • regular screening for all women ≥ 40-50 years of age
          • screening of contralateral breast in LCIS patients
            • LCIS often bilateral in the same quadrant
            • need to do mammography of the contralateral breast at regular intervals
        • diagnosis of breast lump
      • findings
        • LCIS not readily visible on mammography
    • Core needle biopsy
      • indications
        • diagnosis
          • after lump or lesion detected on mammography
          • diagnosis made via histology
            • proliferation of small cells within the breast lobule with small, uniform, oval-shaped nuclei
  • Differential
    • Ductal carcinoma in situ (DCIS)
      • key distinguishing feature
        • histology
          • DCIS will show proliferation of neoplastic epithelial cells within mammary ductal system with no evidence of invasion into surrounding stroma
            • occasional overlap in LCIS and DCIS features
              • immunohistochemical staining used to differentiate
                • DCIS is positive for e-cadherin while LCIS is negative
  • Treatment
    • Medical
      • tamoxifen
        • indications
          • higher-risk patients to reduce future invasive carcinoma risk
      • close follow-up
        • frequent scheduled exams
        • mammographic screening of both breasts
    • Surgical
      • excisional biopsy
        • indications
          • high-risk patients
      • bilateral mastectomy
        • indications
          • to reduce risk of developing invasive carcinoma in ipsilateral or contralateral breast
            • in patients who have family history of premenopausal breast carcinoma
  • Complications
    • Development of invasive carcinoma
  • Prognosis
    • Very good
      • majority of women with LCIS will not develop invasive breast cancer
1 of 0
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options